AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
|Articles|October 11, 2007
NACDS' Robert J. Bolger has passed away
Robert J. Bolger has died
Advertisement
Robert J. Bolger, the first president/CEO of the National Association of Chain Drug Stores (NACDS), died on Monday, Oct. 8. Bolger served NACDS from 1962 to 1987. He was elected NACDS president and CEO in 1967. Subsequently, he served as a member of the NACDS Honorary Board.
To go to the Drug Topics homepage,
Advertisement
Related to this article
Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Must Guide Peptide Talks Pending FDA Action | NCPA 2026
2
FAQ: Scaling Pharmacy Services Through GLP-1 Care | NCPA 2026
3
Pharmacists Improve Access, Safe Use of Obesity Medications
4
FDA Approves Brytly for OTC Eye Redness Relief
5